Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

From Adipose Tissue to Cardiac Repair: Extracellular Vesicles in Cardiovascular Regeneration.

Ignaczak K., Ochocka P., Sadowski K., Ploch W., Tomkiel D., Tomaniak M.

Narrative Review on Cardiovascular Disease, Immune Modulation, published in J Cell Mol Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Cell Mol Med (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42057415
PMCID
PMC13129225
DOI
10.1111/jcmm.71148
NCT
NCT00426868

Abstract (original English)

Adipose-derived extracellular vesicles (ADEVs) secreted by adipose tissue have gained increasing attention due to their regenerative and immunomodulatory properties in cardiovascular diseases. They carry proteins, lipids, and nucleic acids that mediate intercellular communication and influence cardiac pathophysiology. In atherosclerosis, ADEVs promote vascular regeneration, protect endothelial integrity, modulate macrophage polarization, foam cell formation, and regulate lipid homeostasis. In myocardial infarction, they limit apoptosis, reduce fibrosis, stimulate angiogenesis, and regulate inflammation through miRNA-dependent paracrine mechanisms. While preclinical studies support their therapeutic relevance, clinical translation remains at an early stage due to fragmented evidence and lack of standardization in isolation methods, dosing, and safety assessment. This review synthesizes current pathophysiological and translational evidence on the role of ADEVs in cardiovascular repair and provides a structured perspective to guide the development of ADEV-based therapies toward clinical application.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansExtracellular VesiclesAdipose TissueRegenerationAnimalsCardiovascular DiseasesMyocardium

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research